Clinical Trial: A Clinical Study of Topical Baicalein for Cutaneous Adverse Events Associated with Targeted Therapy and Immunotherapy in Cancer Patients (China)

China, Aug. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Clinical Study of Topical Baicalein for Cutaneous Adverse Events Associated with Targeted Therapy and Immunotherapy in Cancer Patients'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129926

Registration Time: 2026/08/11

Type: Interventional study

Primary Sponsor: Nanjing Tianyinshan Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=333766

Published by HT Digital Content Services with permission from Health Daily Digest....